Supernus Pharmaceuticals Inc (SUPN)
Deferred Revenue
$0.00
Quarterly · Period ending: · USD
SUPN Deferred Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
SUPN Quarterly Deferred Revenue ($0.00 → $0.00)
Quarterly deferred revenue
High-resolution chart · PNG
SUPN deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 140,523,000 | |
| 133,865,000 | |
| 138,790,000 | |
| -2,183,000 | |
| -1,892,000 | |
| -1,659,000 | |
| -1,432,000 | |
| 287,000 | |
| 287,000 | |
| 287,000 | |
| 287,000 | |
| 209,000 | |
| 207,000 | |
| 208,000 | |
| 208,000 | |
| 176,000 | |
| 143,000 | |
| 143,000 | |
| 143,000 | |
| 143,000 | |
| 143,000 | |
| 143,000 | |
| 12,444,000 | |
| 8,086,000 | |
| 10,599,000 | |
| 4,292,000 | |
| 3,968,000 | |
| 508,000 | |
| 576,000 | |
| 365,000 | |
| 232,000 | |
| 232,000 | |
| 135,000 | |
| 0 | |
| 0 | |
| 0 |